Abstract
Background: Pax7+ satellite cells are required for skeletal muscle fiber growth during post-natal development in mice. Satellite cell-mediated myonuclear accretion also appears to persist into early adulthood. Given the important role of satellite cells during muscle development, we hypothesized that the necessity of satellite cells for adaptation to an imposed hypertrophic stimulus depends on maturational age. Methods: Pax7CreER-R26RDTA mice were treated for 5 days with vehicle (satellite cell-replete, SC+) or tamoxifen (satellite cell-depleted, SC-) at 2 months (young) and 4 months (mature) of age. Following a 2-week washout, mice were subjected to sham surgery or 10 day synergist ablation overload of the plantaris (n = 6-9 per group). The surgical approach minimized regeneration, de novo fiber formation, and fiber splitting while promoting muscle fiber growth. Satellite cell density (Pax7+ cells/fiber), embryonic myosin heavy chain expression (eMyHC), and muscle fiber cross sectional area (CSA) were evaluated via immunohistochemistry. Myonuclei (myonuclei/100 mm) were counted on isolated single muscle fibers. Results: Tamoxifen treatment depleted satellite cells by ≥90% and prevented myonuclear accretion with overload in young and mature mice (p < 0.05). Satellite cells did not recover in SC- mice after overload. Average muscle fiber CSA increased ~20% in young SC+ (p = 0.07), mature SC+ (p < 0.05), and mature SC- mice (p < 0.05). In contrast, muscle fiber hypertrophy was prevented in young SC- mice. Muscle fiber number increased only in mature mice after overload (p < 0.05), and eMyHC expression was variable, specifically in mature SC+ mice. Conclusions: Reliance on satellite cells for overload-induced hypertrophy is dependent on maturational age, and global responses to overload differ in young versus mature mice.
Original language | English |
---|---|
Article number | 14 |
Journal | Skeletal Muscle |
Volume | 7 |
Issue number | 1 |
DOIs | |
State | Published - Jul 10 2017 |
Bibliographical note
Publisher Copyright:© 2017 The Author(s).
Funding
This work was supported by grants from the NIH to KAM (AR071753), and to CAP and JJM (AG049806 and AR060701).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | AG049806, AR071753 |
National Institutes of Health (NIH) | |
National Institute of Arthritis and Musculoskeletal and Skin Diseases | R01AR060701 |
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
Keywords
- Development
- Fiber splitting
- Muscle hypertrophy
- Pax7
- Regeneration
- Synergist ablation
ASJC Scopus subject areas
- Orthopedics and Sports Medicine
- Molecular Biology
- Cell Biology